The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lytkina E.A.

I.M. Sechenov First Moscow State Medical University, Moscow

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Bilalova U.G.

I.M. Sechenov First Moscow Medical University

Kochergin N.G.

I.M. Sechenov Moscow Medical Academy

Chernikova E.A.

I.M. Sechenov First Moscow Medical University

The quality of life of the patients presenting with atopic dermatitis and their compliance with external therapy

Authors:

Lytkina E.A., Potekaev N.N., Bilalova U.G., Kochergin N.G., Chernikova E.A.

More about the authors

Read: 1659 times


To cite this article:

Lytkina EA, Potekaev NN, Bilalova UG, et al. . The quality of life of the patients presenting with atopic dermatitis and their compliance with external therapy. Russian Journal of Clinical Dermatology and Venereology. 2011;9(1):45‑48. (In Russ.)

Recommended articles:
Infe­ctious factors in atopic dermatitis, pharmaceutical possibilities (systematic lite­rature review). Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):7-15
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
The effect of a gami­fication on healthy indi­viduals’ motor acti­vity. Russian Journal of Preventive Medi­cine. 2025;(4):111-116

References:

  1. Kochergin N.G. Atopicheskii dermatit, chuvstvitel'nye uchastki kozhi i vybor naruzhnoi terapii. Vest dermatol venerol 2009;4:80-85.
  2. Arzumanyan V.G., Serdyuk O.A. Diagnosticheskii antigennyi preparat iz drozhzhei Malassezia furfur. Uspekhi meditsinskoi mikologii. Vserossiiskii mikologicheskii kongress, 4-i: Materialy. M 2006;8:71-73.
  3. Scheynius A. et al. Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Allergy Immunol 2002;127:3:161-169.
  4. Zargari A., Midgley G., Back O. et al. IgE-reactivity to seven Malassezia species. Allergy 2003;58:4:306-311.
  5. Sobolev A.V., Kotrekhova L.P. i dr. Rol' gribov Malassezia furfur pri atopicheskom dermatite. Uspekhi meditsinskoi mikologii. Vserossiiskii mikologicheskii kongress, 4-i: Materialy. M 2006;7:83-84.
  6. Aspres N., Anderson C. Malassezia yeasts in the pathogenesis of atopic dermatitis. Austral J Dermatol 2004;45:4:199-207.
  7. Petkovic L., Kranjcic-Zec I. First case of Malassezia globosa isolation in Serbia. Srp Arh Celok Lek 2003;131:11-12:454-457.
  8. Faergemann J.N. The Role of Malassezia in skin diseases. CD EADV 2010;S28.5.
  9. Mansouri P. et al. Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, and normal subjects. CD EADV 2009;FC04.5.
  10. L'vov A.N. Osobennosti psikhosomaticheskogo statusa bol'nykh atopicheskim dermatitom: Avtoref. dis. … kand. med. nauk. M 2001.
  11. Vivier A., Stoughton S. Tachyphylaxis to the action of topically applied corticosteroids. Arch Dermatol 1975;111:581-583.
  12. Miller J. et al. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids. J Am Acad Dermatol 1999;41:546-549.
  13. Carroll C.L. et al. Adherence to topical therapy decreases during the course of an 8-week clinical trial. J Am Acad Dermatol 2004;51:212-216.
  14. Chambers C.A. et al. An economic analysis of tacrolimus ointment used as maintenance treatment versus standard treatment in patients with moderate to severe atopic dermatitis in Norway. CD EADV 2010;P62.
  15. Paul C. Exploring safety in the long term. CD EADV 2010;SAT13.1.
  16. Poole C.D. et al. Health related utility & cost-effectiveness of treatment with tacrolimus ointment vs topical corticosteroids for adults with moderate to severe atopic dermatitis. CD EADV 2010;P90.
  17. Akdis C.A. et al. Diagnosis and treatment of atopic dermatitis in children and adults: PRACTALL Consensus Report. J Allergy Clin Immunol 2006;118:152-169.
  18. Ashcroft D.M. et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. Br Med J 2005;330:516.
  19. Hultsch T., Kapp A., Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005;211:174-187.
  20. Mokronosova M.A. Allergiya na drozhzhi roda Malassezia u bol'nykh atopicheskim dermatitom. Lech vrach 2009;4:45-47.
  21. Tajima M. Malassezia species in patients with seborrheic dermatitis and atopic dermatitis. Nippon Ishinkin Gakkai Zasshi 2005;46:3:163-167.
  22. Sugita T. Tajima M. et al. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 2005;43:6:2824-2829.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.